Ad Scientiam selected for the European Healthcare Startup Investment Mission to the United States

March 3, 2017

Organized by the U.S. Department of Commerce and SelectUSA, this program has been designed for high-growth startups in the healthcare IT, healthcare services, and health tech industries with secured investments that are planning to scale and expand in the United States.

This mission is a five-day tour through three major American healthcare hubs (Pittsburgh, PA, Cleveland, OH and Austin, TX), connecting participants to potential partners, customers, and industry leaders (March 6 -10, 2017).

It includes workshops and networking events tailored to help startups succeed in the United States, but also meetings with leaders in the healthcare space who will help the startups build relationships with commercial partners, and key players in the healthcare sector.

Ad Scientiam has been retained after a selective screening process among with 9 startups from 6 countries: Desktop Genetics (UK), KairaMedics (Italy), Lumeon (UK), PhysioWizard (Scotland), Raremark (UK), RTSafe (Greece), SIBAsoft (Greece), SilverCloud (Ireland), Trialbee (Sweden)


MSCopilot®: New clinical results confirm central role of digital biomarkers in the monitoring of patients with multiple sclerosis Our news